Your new post is loading...
Patients who take medications as doctors direct may save as much as $7,800 each year.
An Eyeforpharma report has some great information on adherence. There are many reasons given by patients for not adhering to their prescribed treatment. The most obvious are that they simply forgot to take their medicine. This generally corresponds to only about 30% to 40% of cases. In other words, up to 70% of non-adherence is voluntary; people decide not to follow their therapy, either discontinuing it altogether (i.e. not being persistent) or not taking it as often as they should (non-compliant). Why?
Different studies supply different answers to that question, but they can generally be grouped into the following categories:
- Concerns about the medication ...
- Impression that the medication is unnecessary ...
- Financial worries ...
- Forgetfulness ...
- Cultural or religious beliefs ...
- Depression ...
- Inability to follow treatment ...
The relative importance of these seven factors vary greatly across different patients, geographies and pathologies. Any effort by the pharmaceutical industry to support patients must first understand what they need, what the specific drivers are for non-adherence in the case of the treatment in question
Consider these faacts:
"US physicians spend on average 16 minuteswith a patient, but only 49 seconds explaining new treatments"
Of those 49 seconds, are spent talking about directions for administration and about side effects, while a clear understanding of side effects before initiating treatment has a positive as opposed to a negative effect on adherence.
Increased adherence to hypertension and cholesterol medicines would reduce healthcare spending by $4 to $5 for every new dollar spent on medicines.
A 10% adherence to asthma medications was associated with a nearly 5% decrease in total annual medical spending.
Patients who take medications as doctors direct may save as much as $7,800 each year.
Via rob halkes
The issue of adherence behaviour to therapy by patients begins with the conceptualization of what one understands with it: Is it just an order, or object for discussion, perhaps to tailor it to patients abilities.. Or shouldn't one think that if patients do not as they're told, they must take the consuqeunces...
The report suggests that it is not as simple as that. Necessary to know!
As it is about phama's products, I do think that this is a fundamental tasks to help their clients, the prescribing doctors, to help their patients in this!